Nachrichten zur Johnson & Johnson Aktie

Johnson Controls plc-Aktie kann Vortagsniveau nicht halten (81,4065 €)

Im Minus liegt aktuell die Aktie von Johnson Controls plc . Der jüngste Kurs betrug 85,13 US-Dollar. Ein Kursabschlag in…

Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income

Kenvue (NYSE: KVUE) stock is down since completing its spin-off from Johnson & Johnson (NYSE: JNJ) in August 2023. But…

Johnson Johnson: Die Marken des Unternehmens

Johnson Johnson steht - ähnlich wie auch andere Grosskonzerne - hinter vielen Marken, von denen Kunden oft gar nicht…

Johnson & Johnson (JNJ) Laps the Stock Market: Heres Why

The latest trading day saw Johnson & Johnson (JNJ) settling at $157.89, representing a +1.87% change from its previous close.…

Carlsberg, Johnson & Johnson Tap Europe Market for M&A Bonds

Carlsberg Breweries A/S and Johnson & Johnson sold the first major buyout debt of the year in Europe’s primary market…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Genmab: Positive 2025 Outlook, Johnson & Johnsons Decision Coming Soon

…

Johnson & Johnson: Rich History Of Excellence Poised To Endure

…

Johnson Controls: Growth At An Attractive Price

…

Whats a Fair Price to Buy Johnson & Johnson Stock?

Johnson & Johnson (NYSE: JNJ) is forecast to increase its free cash flow significantly over the next five years and…

Dividenden-Aristokrat Johnson & Johnson: Sparten-Verkauf geplant

Der amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson will sich laut einem Bericht der Financial Times (FT) von seinem Schlaganfall-Geschäft…

Dividenden-Aristokrat Johnson & Johnson: Sparten-Verkauf geplant

Der amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson will sich laut einem Bericht der Financial Times (FT) von seinem Schlaganfall-Geschäft…

Dividenden-Aristokrat Johnson & Johnson: Sparten-Verkauf geplant

Der amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson will sich laut einem Bericht der Financial Times (FT) von seinem Schlaganfall-Geschäft…

Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times By Investing.com

Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times…

Johnson & Johnson Aktie: Verkauf des Schlaganfall-Geschäfts geplant

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson Controls upgraded at UBS on new chief executive

…

UBS upgrades this HVAC equipment maker after the appointment of a new CEO

UBS turned bullish on Johnson Controls shares after the company appointed a new chief executive.…

2 Stocks to Buy if There Is a Market Crash in 2025

Equity markets have been volatile over the past week as some of the industry leaders in artificial intelligence (AI) --…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average (DJINDICES: ^DJI) may be the most elite club in the stock market. The vaunted index holds…

Solvonis Therapeutics: A new player in the $450bn “neuro-psych” sector

In the world of life sciences, deal flow often serves as a barometer for emerging trends. The recent acquisitions by…

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

The Johnson Group continues tradition of hometown investing

Searching for a project that would give people a reason to come downtown led The Johnson Group team to consider…

Johnson Controls Q1 Earnings & Revenues Surpass Estimates, Rise Y/Y

JCIs fiscal first-quarter revenues increase 10% year over year, driven by strength in the HVAC & controls businesses.…

Johnson Controls (JCI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Johnson Controls (JCI) give a sense of how the business performed in the…

Johnson Controls raises FY 2025 EPS guidance to $3.50-$3.60 amid strong Q1 performance

…

Johnson Controls lifts 2025 profit forecast, names new CEO By Reuters

Johnson Controls lifts 2025 profit forecast, names new CEO…

Johnson Controls lifts 2025 profit forecast, names new CEO

Johnson Controls International named Joakim Weidemanis as chief executive officer and lifted its 2025 profit forecast on Wednesday, sending its…

Johnson Controls stock surges 8% on earnings beat, raised guidance By Investing.com

Johnson Controls stock surges 8% on earnings beat, raised guidance…

Johnson Outdoors Q1 Earnings Lag Estimates, Sales Beat, Stock Tumbles

JOUTs first-quarter fiscal 2024 results reflect dismal market demand trends and competitive risks. Click away to get a clear picture…

Medical Device Makers Seek Exemption From Trump Tariffs

Medical device makers including Abbott, Johnson & Johnson and Medtronic want an exemption from Trump tariffs that could hit the…

Johnson Outdoors Inc. (JOUT) Q1 2025 Earnings Call Transcript

…

Johnson Outdoors Reports Fiscal First Quarter Results

RACINE, Wis., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…

The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern

NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern are included in this Analyst Blog.…

Is Johnson & Johnson Stock a Buy?

Johnson & Johnson (NYSE: JNJ) is one of the worlds largest and most prominent healthcare leaders. If investing in a…

Johnson & Johnson Aktie: Kursziel gesteigert

London (www.aktiencheck.de) - Rating-Update: Die Empfehlung von Barclays für die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN: 853260, Ticker-Symbol:…

Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stocks Fortunes Around?

Johnson & Johnson (NYSE: JNJ) has a diverse healthcare business, and investors often look to it as a safe dividend…

Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Johnson & Johnson (NYSE: JNJ) didnt have an exceptional 2024; in fact, it was one of the worst-performing stocks on…

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and…

US government could seek over $1 billion from J&J for cancer treatment costs

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for…

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and…

Why Johnson & Johnsons Strong Buy Rating Is Justified (Rating Upgrade)

…

J&J-Backed Medtech Firm HistoSonics Considers US IPO

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US initial…

Spravato sales growth highlights commercial viability of psychedelics, analysts believe

The latest quarterly sales figures for Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray support the notion that psychedelics can become…

Prediction: This Company Will Have a Trillion-Dollar Market Cap by 2040

The list of companies with market caps of $1 trillion or more remains extremely short. However, theres little doubt that…

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. Its often looked at as a…

Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?

Shares of robotic surgery pioneer Intuitive Surgical (NASDAQ: ISRG) have been soaring lately. A preliminary look at sales results from…

Johnson & Johnson Aktie: Kursziel reduziert

New York (www.aktiencheck.de) - Rating-Update: Sanford C. Bernstein hat das Kursziel für die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…

Johnson & Johnson Aktie: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley haben das Kursziel für Johnson & Johnson (ISIN: US4781601046, WKN: 853260,…